ACTIVE SESSION TAPE Biotechnology $30M Cap Quant: HOLD

Why Is Iterum Therapeutics plc Ordinary Share (ITRM) Stock Down Today?

Updated Nov 22, 2026 6:19 AM ET ยท Prev Close $0.07

Pro Workspace
Last Session Price
$0.03 -57.39%
-$0.04 vs $0.07 prior close
Intraday Range
$0.03 โ€“ $0.05
Open $0.04
Relative Volume
0.20x Avg
58,645,688 sh
52-Week Range
$0.03 โ€“ $0.10
Benchmark Alpha
-53.75% vs SPY
-51.72% vs QQQ
20-Session Trend -15.7%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

Iterum Therapeutics plc Ordinary Share Pulling Back 57.39% on 0.20x Relative Volume

Iterum Therapeutics plc Ordinary Share (ITRM) is pulling back 57.39% (-$0.04) to $0.03 on 0.20x average session volume. Relative to benchmarks, ITRM is lagging the S&P 500 by -53.75%. 14-day RSI stands at 25.9, keeping momentum in a oversold regime.

NEWS 70% Weight
Iterum Therapeutics plc Nasdaq Itrm Are Analysts Optimistic?

We feel now is a pretty good time to analyse Iterum Therapeutics plc's Nasdaq Itrm business as it appears the...

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.03) trades relative to 20-day SMA ($0.15) and 50-day SMA ($0.23).

Volume Confirmation
LOW VOLUME (0.20x) Consolidation
Sub-average participation โ€” monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

ITRM lagging the S&P 500 by -53.75%
ITRM Session
-57.39%
$0.03
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: -53.75% Alpha vs QQQ: -51.72% Alpha vs XLV: -57.27%

Options Flow & Execution Desk

Recent ITRM Catalyst Headlines

Verified Wire
Iterum Therapeutics Announces Filing of Winding Up Petition

DUBLIN and Chicago, March 27, 2026 Globe Newswire -- Iterum Therapeutics plc in Provisional Liquidation Nasdaq ITRM the Company or Iterum or we , a company focused on delivering next generation oral and IV antibiotics to

Yahoo Finance ยท Mar 27, 2026
Iterum Therapeutics Provides Business Update

--Expanded Market Access and Patent Protection for Orlynvah --FDA correspondence regarding the use of Orlynvah as step-down therapy DUBLIN and Chicago, Feb. 13, 2026 Globe Newswire -- Iterum Therapeutics plc Nasdaq ITRM

Yahoo Finance ยท Feb 13, 2026

1โ€“3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$0.03
Short-term support band
Upper Bound
$0.03
Short-term resistance band
Key Inflection Level
$0.03 (session support)

Monitor volume expansion above 1.5x RVOL around $0.03 (session support) for directional breakout confirmation.

Technical Regime (ITRM)

BEARISH MA TREND
RSI (14)
25.9
Oversold
20-Day SMA
$0.15
Below 20d
50-Day SMA
$0.23
Below 50d
MACD Signal
Bearish
MACD -0.04
ADX (14)
27.6
Strong trend
10d Momentum
-0.14
Soft 10-day momentum

Retail & Crowd Sentiment

Bearish
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

StockTwits messages indicate bullish sentiment towards $ITRM with traders expressing confidence in its potential growth and faster Irish High Court liquidation process. No recent news articles were available.

Reddit communities: 1 comment (Bearish)

About Iterum Therapeutics plc Ordinary Share

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the โ€ฆ

Sector
Healthcare
Market Cap
$30M
Employees
9

Get Instant ITRM Catalyst Alerts

Receive an email alert when ITRM triggers an unusual volume breakout, options sweep, or rating shift.

ITRM Session & Catalyst FAQ

Why is ITRM stock down today?

Iterum Therapeutics plc Ordinary Share (ITRM) is pulling back 57.39% (-$0.04) to $0.03 on 0.20x average session volume. Relative to benchmarks, ITRM is lagging the S&P 500 by -53.75%. 14-day RSI stands at 25.9, keeping momentum in a oversold regime.

Is ITRM stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.20x relative volume (low participation). Our multi-factor model currently rates ITRM as HOLD. Review full valuation, quality, and timing signals on the ITRM Buy or Sell Decision Brief โ†’

What is ITRM's intrinsic value and expected trading range?

At $0.03, ITRM's modeled 1-to-3 session range is $0.03 โ€“ $0.03, with a key inflection level at $0.03 (session support). Compare current price against multi-year cash flow projections in the ITRM Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for ITRM?

RSI at 25.9 indicates oversold conditions โ€” watch for mean-reversion support. ITRM trades at $0.03 relative to its 20-day SMA ($0.15) and 50-day SMA ($0.23), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs